gut
microbiota
play
critic
role
gut
health
host
protect
enteropathogen
extract
nutrient
energi
food
contribut
normal
immun
function
disrupt
normal
composit
gut
microbiota
associ
obes
malnutrit
inflammatori
bowel
diseas
neurolog
disord
sever
alter
normal
human
gut
microbiota
document
particularli
diarrhoeal
diseas
antibioticassoci
inflammatori
bowel
acut
post
radiotherapi
irrit
bowel
previou
studi
faecal
microbiota
neonat
calv
firmicut
abund
phylum
preval
rang
follow
bacteroidet
proteobacteria
fusobacteria
actinobacteria
chang
digest
tract
microbiom
also
identifi
cattl
exhibit
shift
faecal
microbiota
cattl
infect
mycobacterium
avium
subsp
paratuberculosi
john
diseas
limit
inform
avail
effect
infecti
diarrhoeal
pathogen
faecal
microbiota
cattl
cryptosporidium
parvum
coccidian
protozoan
parasit
caus
enter
infect
diarrhoeal
diseas
mani
mammal
includ
immunocompet
immunocompromis
parasit
wide
distribut
common
caus
sever
neonat
diarrhoea
among
calv
cryptosporidiosi
one
import
infecti
diarrhoeal
diseas
caus
protozoa
cattl
industri
cryptosporidiosi
usual
mild
selflimit
immunocompet
human
individu
variou
immun
disord
includ
acquir
immun
defici
syndrom
often
contract
chronic
lifethr
nitazoxanid
licens
treatment
cryptosporidiuminduc
diarrhoea
efficaci
calv
remain
although
one
studi
report
benefici
effect
nitazoxanid
treatment
cryptosporidiosi
experimentallyinfect
neonat
anoth
studi
reveal
prophylact
therapeut
therefor
clinic
diseas
control
calv
hamper
lack
drug
vaccin
effect
either
treatment
prevent
gut
microbiota
thought
affect
resist
c
parvum
infect
germfre
adult
immunocompet
mice
show
high
suscept
moreov
studi
use
sever
combin
immunodefici
scid
mice
support
hypothesi
resist
adult
mice
c
parvum
infect
requir
specif
immun
respons
mediat
nonspecif
mechan
associ
presenc
intestin
hypothesi
base
result
show
c
parvum
readili
detect
florabear
adult
scid
mice
germfre
scid
mice
heavili
infect
follow
challeng
observ
indic
interact
occur
c
parvum
faecal
microbiota
infect
host
administr
live
lactobacillu
bacteri
cellfre
supernat
reduc
viabil
c
parvum
oocyst
furthermor
probiot
limit
c
parvum
infect
immunocompromis
individu
mous
model
similar
result
observ
human
howev
probiot
treatment
calv
infect
c
parvum
result
signific
decreas
incid
diarrhoea
oocyst
shed
compar
present
noth
known
faecal
microbiota
neonat
calv
infect
c
parvum
interact
faecal
microbiota
c
parvum
must
analys
understand
pathophysiolog
chang
occur
diseas
progress
address
knowledg
gap
examin
faecal
microbiota
profil
neonat
calv
c
parvumendem
farm
metagenom
sequenc
analysi
conduct
use
ionpgm
composit
microbiota
reveal
highthroughput
sequenc
reexamin
confirm
quantit
polymeras
chain
reaction
qpcr
analysi
moreov
neonat
calv
differ
region
japan
examin
evalu
univers
observ
alter
faecal
microbiota
caus
c
parvum
infect
metagenom
analysi
base
rrna
gene
sequenc
perform
total
faecal
sampl
collect
six
time
point
neonat
holstein
calv
tabl
calv
age
day
old
locat
farm
farm
iwat
prefectur
japan
calv
femal
born
ident
cattl
shed
birth
weight
rang
kg
treatment
birth
includ
colostrum
practic
ident
calv
distribut
rel
abund
differ
bacteri
genera
shown
fig
three
group
c
parvumonlyinfect
n
rotavirusonlyinfect
n
pathogenneg
group
n
determin
commerci
immunochromatograph
test
ict
strip
biox
diagnost
sprl
jemel
belgium
none
anim
test
posit
coronaviru
infect
abund
genu
c
parvumonlyinfect
calv
fusobacterium
averag
sampl
follow
escherichiashigella
rel
ratio
fusobacterium
low
rotavirusonlyinfect
pathogenneg
group
rel
ratio
escherichiashigella
two
group
respect
similar
observ
c
parvuminfect
group
fig
tabl
abund
fusobacterium
appear
increas
faecal
microbiota
c
parvumonlyinfect
calv
fig
signific
increas
found
abund
bacteria
day
old
day
old
sampl
point
fig
wilcoxon
test
p
signific
increas
detect
rotavirusonlyinfect
n
pathogenneg
calv
n
fig
genusspecif
increas
observ
among
top
genera
identifi
c
parvumonlyinfect
sampl
list
fig
result
metagenom
analysi
reproduc
qpcr
assay
sampl
point
day
old
fig
specif
increas
abund
fusobacterium
detect
c
parvumonlyinfect
calv
n
comparison
rotavirusonlyinfect
n
pathogenneg
calv
n
signific
differ
observ
c
parvumposit
group
group
kruskalw
test
p
increas
abund
fusobacterium
also
detect
day
old
c
parvumposit
calv
farm
locat
okinawa
n
kagoshima
n
iwat
n
hokkaido
n
prefectur
supplementari
fig
age
calv
similar
calv
farm
sampl
point
day
old
increas
abund
fusobacterium
observ
c
parvumposit
calv
n
increas
detect
c
parvumneg
calv
n
fig
moreov
fusobacterium
load
show
strong
posit
correl
c
parvum
r
p
fig
fisher
exact
test
reveal
number
fusobacteriumpositivec
parvumposit
sampl
significantli
greater
number
fusobacteriumpositivec
parvumneg
sampl
differ
locat
okinawa
kagoshima
iwat
hokkaido
prefectur
p
tabl
number
c
parvum
oocyst
detect
infect
neonat
calv
farm
increas
day
fig
rel
ratio
fusobacterium
began
increas
time
point
fig
faecal
score
indic
sever
diarrhoea
increas
accord
abund
c
parvum
fusobacterium
fig
moder
posit
correl
observ
number
oocyst
rel
ratio
fusobacterium
r
p
fig
metagenom
analysi
conduct
studi
reveal
abund
fusobacterium
particularli
increas
c
parvumonlyinfect
calv
fig
although
fusobacterium
speci
detect
studi
identifi
specif
increas
fusobacterium
among
c
parvumposit
sampl
farm
confirm
qpcr
analysi
fig
fusobacterium
speci
anaerob
elong
gramneg
rod
multipl
speci
fusobacterium
speci
commonli
associ
human
anim
diseas
f
necrophorum
opportunist
pathogen
caus
numer
necrot
condit
necrobacillosi
specif
nonspecif
infect
varieti
anim
bovin
liver
abscess
foot
rot
caus
f
necrophorum
signific
concern
cattl
factor
environ
diet
shape
human
faecal
microflora
remain
unclear
nonetheless
studi
reveal
increas
level
prevotella
bacteroid
respons
highfibr
diet
longterm
diet
rich
anim
protein
calv
probiot
administr
use
lactic
acid
bacteria
identifi
tool
maintain
intestin
microbi
balanc
prevent
establish
opportunist
therefor
dietari
differ
farm
especi
presenc
absenc
probiot
supplement
like
affect
composit
faecal
microbiota
calv
howev
studi
specif
increas
fusobacterium
observ
anim
farm
also
calv
complet
differ
locat
tabl
fig
suggest
growth
fusobacterium
common
featur
among
c
parvumposit
calv
regardless
differ
diet
environment
condit
farm
oocyst
shed
pattern
c
parvum
observ
studi
fig
similar
record
previou
interestingli
initi
oocyst
shed
day
old
appear
coincid
increas
fusobacterium
day
old
fig
protozoan
infect
occur
prior
increas
fusobacterium
growth
oocyst
incub
period
dairi
cattl
day
prior
moreov
rel
ratio
bacteria
tend
increas
accord
increas
number
oocyst
fig
observ
suggest
increas
c
parvum
may
benefit
growth
fusobacterium
benefici
interact
two
microb
appear
univers
base
strong
posit
correl
c
parvum
fusobacterium
observ
faecal
sampl
differ
origin
fig
previou
studi
reveal
cryptosporidiosi
symptom
strongli
correl
load
c
parvum
host
faecal
sampl
challeng
human
volunt
c
parvum
show
number
oocyst
excret
faec
significantli
higher
subject
diarrhoea
enter
symptom
addit
previou
studi
risk
factor
neonat
calf
diarrhoea
caus
c
parvum
report
signific
associ
high
oocyst
number
occurr
present
studi
faecal
score
appear
worsen
fig
correspond
increas
abund
c
parvum
fig
fusobacterium
fig
therefor
increas
fusobacterium
appear
import
aggrav
factor
cryptosporidiosi
growth
bacterium
increas
c
parvum
load
neonat
calv
fig
anim
model
use
neonat
calv
c
parvum
challeng
requir
futur
gather
direct
evid
coincreas
c
parvum
fusobacterium
propos
specif
increas
fusobacterium
may
caus
follow
mechan
damag
microvilli
surfac
intestin
epitheli
cell
caus
growth
c
parvum
increas
suscept
fusobacterium
infect
fusobacterium
becom
domin
genu
grow
effect
abil
adher
invad
intestin
may
caus
sever
diarrhoea
cattl
hypothesi
remain
unconfirm
patholog
analysi
intestin
cell
need
understand
benefici
interact
c
parvum
fusobacterium
clinic
studi
human
diarrhoeal
shown
fusobacterium
found
colon
tissu
patient
inflammatori
bowel
diseas
fusobacterium
varium
known
caus
agent
ulcer
previou
studi
show
cours
combin
antibiot
therapi
amoxicillin
mg
tetracyclin
mg
metronidazol
mgday
reduc
densiti
f
varium
mucosa
result
higher
remiss
rate
treatment
group
compar
control
present
studi
suggest
kind
antibiot
therapi
target
fusobacterium
may
also
reliev
sever
diarrhoea
cryptosporidiosi
case
first
studi
reveal
signific
correl
fusobacterium
c
parvum
case
neonat
calf
diarrhoea
increas
fusobacterium
faecal
microbiota
like
import
aggrav
factor
cryptosporidiosi
calv
novel
find
may
contribut
develop
improv
control
strategi
cryptosporidiosi
studi
perform
strict
accord
recommend
guid
care
use
laboratori
anim
ministri
educ
cultur
sport
scienc
technolog
japan
protocol
approv
committe
ethic
anim
experi
iwat
univers
permit
number
faecal
sampl
collect
neonat
holstein
calv
farm
farm
iwat
prefectur
japan
cryptosporidiosi
caus
c
parvum
consist
report
neonat
achiev
consist
sampl
qualiti
calv
hous
handl
way
much
possibl
calv
femal
born
ident
cattl
shed
birth
weight
rang
kg
prematur
calv
exclud
sampl
vaccin
programm
implement
neonat
calv
farm
within
h
birth
calv
fed
litr
colostrum
follow
litr
colostrum
twice
daili
day
equival
amount
milk
substitut
potemow
milk
nosan
yokohama
japan
use
thereaft
calf
starter
bio
calf
neo
nosan
fed
calv
period
faecal
sampl
collect
calf
everi
two
three
day
birth
day
age
result
total
faecal
sampl
farm
across
six
sampl
point
sampl
divid
two
plastic
tube
first
tube
half
sampl
analys
presenc
c
parvum
rotaviru
coronaviru
escherichia
coli
antigen
use
commerci
immunochromatograph
test
ict
strip
biox
diagnost
sprl
jemel
belgium
remain
half
faecal
sampl
first
tube
use
calcul
abund
oocyst
describ
faecal
score
sampl
record
time
point
sever
diarrhoea
score
accord
appear
faecal
materi
normal
loos
muddi
wateri
second
tube
sampl
preserv
dna
extract
examin
correl
c
parvum
faecal
microbiom
neonat
calv
differ
origin
faecal
sampl
collect
calv
age
day
born
farm
locat
okinawa
kagoshima
iwat
hokkaido
prefectur
japan
supplementari
fig
age
calv
similar
calv
farm
sampl
point
day
old
faecal
sampl
preserv
dna
extract
powersoil
dna
isol
kit
mobio
laboratori
inc
carlsbad
ca
usa
use
isol
dna
faecal
sampl
farm
differ
locat
iwat
hokkaido
prefectur
qiaamp
dna
stool
mini
kit
qiagen
hilden
germani
use
dna
extract
sampl
okinawa
kagoshima
prefectur
librari
prepar
primer
set
r
target
region
rrna
gene
bacterium
ion
plu
fragment
librari
kit
life
technolog
sequenc
perform
use
chip
ion
pgm
sequenc
kit
life
technolog
ion
pgm
sequenc
life
technolog
raw
sequenc
demultiplex
qualitytrim
use
follow
procedur
trim
base
qualiti
less
end
read
ii
remov
read
averag
qualiti
less
iii
remov
read
without
primer
sequenc
end
iv
remov
read
total
length
less
bp
step
carri
use
fastxtoolkit
http
hannonlabcshledufastxtoolkitindexhtml
bbtrim
http
bbmapsourceforgenet
subsequ
read
per
sampl
randomli
sampl
use
randomsequencesamplepl
http
wwwualbertacastothardsoftwarehtml
algorithm
taxonom
assign
sequenc
cluster
oper
taxonom
unit
otu
defin
similar
cutoff
use
uclust
version
repres
sequenc
otu
classifi
taxonom
use
rdp
classifi
version
greengen
databas
qpcr
assay
carri
determin
abund
c
parvum
fusobacterium
sequenc
sampl
faecal
sampl
collect
sampl
point
farm
along
sampl
differ
origin
use
qpcr
analys
determin
abund
c
parvum
sequenc
qpcr
target
rrna
gene
perform
follow
primer
forward
revers
reaction
mixtur
prepar
final
volum
contain
primer
rox
refer
dye
sybr
qpcr
mix
thunderbird
sybr
qpcr
mix
toyobo
co
osaka
japan
templat
dna
qpcr
perform
use
steponeplu
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
initi
denatur
step
follow
cycl
determin
abund
fusobacterium
sequenc
qpcr
target
rrna
gene
perform
use
follow
primer
forward
revers
composit
reaction
mixtur
ident
describ
thermal
cycler
condit
consist
initi
denatur
step
follow
cycl
amount
templat
dna
vari
accord
qualiti
dna
ng
sampl
farm
ng
sampl
okinawa
kagoshima
prefectur
ng
sampl
iwat
hokkaido
prefectur
control
plasmid
contain
rrna
rrna
gene
sequenc
c
parvum
fusobacterium
respect
construct
use
gener
standard
curv
qpcr
assay
briefli
pcr
product
respect
target
clone
use
mighti
clone
reagent
set
blunt
end
takara
bio
inc
otsu
japan
result
plasmid
linearis
digest
ecori
c
parvum
fusobacterium
load
sampl
copi
numberng
dna
determin
base
standard
calibr
curv
gener
qpcr
assay
carri
use
dilut
seri
control
plasmid
qpcr
assay
repeat
least
twice
confirm
reproduc
result
oocyst
number
c
parvumposit
sampl
identifi
ict
strip
determin
use
sugar
flotat
method
describ
briefli
g
faecal
sampl
resuspend
water
centrifug
g
min
supernat
discard
pellet
resuspend
sucros
solut
gml
centrifug
use
condit
follow
centrifug
oocyst
present
sampl
float
top
supernat
could
count
give
approxim
number
oocyst
per
gram
opg
averag
number
oocyst
field
magnif
calcul
optic
microscop
averag
number
convert
opg
use
total
number
field
microscop
total
number
field
optic
microscop
use
studi
olympu
tokyo
japan
statist
analys
perform
use
graphpad
prism
version
graphpad
softwar
inc
wilcoxon
test
perform
compar
distribut
bacteri
rel
abund
sampl
farm
differ
sampl
point
examin
respect
three
group
c
parvumonlyinfect
rotavirusonlyinfect
pathogen
neg
sampl
correl
coeffici
calcul
examin
relationship
number
c
parvum
oocyst
rel
ratio
fusobacterium
well
dna
copi
number
c
parvum
fusobacterium
associ
c
parvum
fusobacterium
base
number
posit
neg
sampl
determin
qpcr
analysi
faecal
sampl
differ
origin
examin
fisher
exact
test
